Safety of Gene Therapy for Mesothelioma

Currently, patients can only receive gene therapy, T cell therapy, and other immune-based therapy as part of a clinical trial. There is no guarantee of safety for participation in any clinical trial, including ongoing gene therapy and T cell therapy trials. We conduct these trials, in large part, to assess the safety and proper dosing of these experimental therapies, but all early-phase trials come with a certain degree of uncertainty and risk of complications. Well-run early-phase trials, however, are conducted by experienced multidisciplinary teams that are trained in early recognition and intervention for any complications and/or side effects.